Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Yu Zhang's research, publications, and ongoing work
Developed a CRISPR-Cpf1 system to correct muscular dystrophy mutations in human cardiomyocytes and mice, demonstrating the potential for therapeutic genome editing.
Successfully corrected diverse muscular dystrophy mutations in human engineered heart muscle using single-site genome editing, paving the way for personalized medicine approaches.
Improved CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice using a self-complementary AAV delivery system, enhancing therapeutic efficacy.
Utilized base editing to correct hypertrophic cardiomyopathy mutations in human cardiomyocytes and humanized mice, offering a novel therapeutic strategy.
Demonstrated that precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy, providing a potential treatment.
Created a novel mouse model (NSG-mdx 4Cv) to study muscular dystrophy and demonstrated functional improvement following allogeneic satellite cell transplantation.
Dr. Yu Zhang is a leading researcher in genome editing, specializing in CRISPR-based therapies for muscular dystrophy and cardiovascular diseases. His work focuses on developing innovative gene editing approaches to correct genetic mutations and improve disease outcomes.
Researchers with overlapping expertise and complementary work
Finding similar researchers...